Top

The Journal of Headache and Pain

Published in:

Open Access 01-10-2009 | Letter to the Editor

Plasma calcitonin gene-related peptide concentration is comparable to control group among migraineurs and tension-type headache subjects during interictal period: response to comments by Tfelt-Hansen and Ashina

Authors: Ravi Gupta, Ahmed Tanzeel, Basudeb Banerjee, Manjeet Bhatia

Published in: The Journal of Headache and Pain | Issue 5/2009

Excerpt

Dear Editor, …

Tfelt-Hansen P, Ashina M (2009) CGRP in migraine. J Headache Pain. doi 10.1007/s10194-009-0139-x

Gupta R, Ahmed T, Banerjee B, Bhatia M (2009) Plasma calcitonin gene-related peptide concentration is comparable to control group among migraineurs and tension type headache subjects during inter-ictal period. J Headache Pain 10:161–166. doi: 10.1007/s10194-009-0110-x, 19277835, 1:CAS:528:DC%2BD1MXls1OksLc%3DPubMedCentralCrossRefPubMed

Goadsby PJ, Edvinsson L, Ekman R (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine attacks. Ann Neurol 28:183–187 1699472, 10.1002/ana.410280213, 1:STN:280:DyaK3M%2FisVSktQ%3D%3DCrossRefPubMed

Tvedskov JF, Lipka K, Ashina M, Iversen HK, Schifter S, Olesen J (2005) No increase of calcitonin gene-related peptide in jugular blood during migraine. Ann Neurol 58:561–563 16178016, 10.1002/ana.20605, 1:CAS:528:DC%2BD2MXhtFGrsL7OCrossRefPubMed

Ashina M, Bendtsen L, Jensen R, Schifter S, Olesen J (2000) Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside attacks. Pain 86:133–138 10779670, 10.1016/S0304-3959(00)00232-3, 1:CAS:528:DC%2BD3cXisFGktbg%3DCrossRefPubMed

Gallai V, Sarchielli P, Floridi A, Franceshini M, Codini M, Glioti G et al (1995) Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia 15:380–384 10.1046/j.1468-2982.1995.1505384.xCrossRef

Fusayasu E, Kowa T, Takeshima T, Nakaso K, Nahashima K (2007) Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods. Pain 128:209–214 17123735, 10.1016/j.pain.2006.09.017, 1:CAS:528:DC%2BD2sXis1Oqsbo%3DCrossRefPubMed

Friberg L, Olesen J, Skyhøj Olsen T, Karle A, Ekman R, Fahrenkrug J (1994) Absence of vasoactive peptide release from brain to cerebral circulation during onset of migraine with aura. Cephalalgia 14:47–54 7515329, 10.1046/j.1468-2982.1994.1401047.x, 1:STN:280:DyaK2c3lvVOjsw%3D%3DCrossRefPubMed

Sarchielli P, Alberti A, Codini M, Floridi A, Gallai V (2000) Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia 20:907–918 11304026, 10.1046/j.1468-2982.2000.00146.x, 1:STN:280:DC%2BD3MvntlSgsg%3D%3DCrossRefPubMed

10.

Kraenzlin ME, Ch’ng JLC, Mulderry PK, Ghatei MA, Bloom R (1985) Infusion of a novel peptide, calcitonin gene-related peptide (CGRP) in man: pharmacokinetics and effects on gastric acid secretion and gastrointestinal hormones. Regul Pept 10:189–197 3922013, 10.1016/0167-0115(85)90013-8, 1:CAS:528:DyaL2MXhsl2rtrw%3DCrossRefPubMed

11.

Struthers AD, Brown MJ, Macdonald DW, Beacham JL, Stevenson JC, Morris HR, MacIntyre I (1986) Human calcitonin gene related peptide: a potent endogenous vasodilator in man. Clin Sci 70:389–393 3486086, 1:CAS:528:DyaL28XitVWju7c%3DCrossRefPubMed

12.

Frese A, Schilgen M, Edvinsson L, Frandsen E, Evers S (2005) Calcitonin gene-related peptide in cervicogenic headache. Cephalalgia 25:700–703 16109051, 10.1111/j.1468-2982.2004.00940.x, 1:STN:280:DC%2BD2Mvkt1agtg%3D%3DCrossRefPubMed

13.

Kruuse C, Frandsen E, Schifter S, Thomsen LL, Birk S, Olesen J (2004) Plasma levels of cAMP, cGMP and CGRP in sildenafil-induced headache. Cephalalgia 24:547–553 15196297, 10.1111/j.1468-2982.2003.00712.x, 1:STN:280:DC%2BD2cvit12ktg%3D%3DCrossRefPubMed

14.

Wimalwasna SJ (1991) Circadian variation of plasma calcitonin gene related peptide in men. J Neuroendocrinol 3:319–322 10.1111/j.1365-2826.1991.tb00281.xCrossRef

15.

de los Santos ET, Mazzaferri EL (1991) Calcitonin gene related peptide: 24 h profile and response to volume contraction and expansion in normal men. J Clin Endocrinol Metab 72:1031–1035 10.1210/jcem-72-5-1031CrossRef

16.

Larsen A, Bronstein IB, Dahl B, Wentzel-Larsen T, Kristofferson EK, Fagerhol MK (2007) Quantification of S100A12 (EN-RAGE) in blood varies with sampling method, heparin and calcium. Scand J Immunol 65:192–201 17257225, 10.1111/j.1365-3083.2006.01875.x, 1:CAS:528:DC%2BD2sXjsVKrsbk%3DCrossRefPubMed

Title: Plasma calcitonin gene-related peptide concentration is comparable to control group among migraineurs and tension-type headache subjects during interictal period: response to comments by Tfelt-Hansen and Ashina
Authors: Ravi Gupta
Ahmed Tanzeel
Basudeb Banerjee
Manjeet Bhatia
Publication date: 01-10-2009
Publisher: Springer Milan
Published in: The Journal of Headache and Pain / Issue 5/2009
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI: https://doi.org/10.1007/s10194-009-0141-3

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Plasma calcitonin gene-related peptide concentration is comparable to control group among migraineurs and tension-type headache subjects during interictal period: response to comments by Tfelt-Hansen and Ashina

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2009

Riboflavin prophylaxis in pediatric and adolescent migraine

Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism

CGRP in migraine

Who’s still afraid of the link between headache and epilepsy? Some reactions to and reflections on the article by Marte Helene Bjørk and co-workers

What can be learned from the history of recurrence in migraine? A comment

SUNCT and optic nerve hypoplasia